Published in Am J Pathol on April 01, 1994
NFATc1 balances quiescence and proliferation of skin stem cells. Cell (2008) 3.81
Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82
A Guide to Studying Human Hair Follicle Cycling In Vivo. J Invest Dermatol (2016) 1.46
p53 Involvement in the control of murine hair follicle regression. Am J Pathol (2001) 1.19
Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol (1997) 1.17
Prevention of chemotherapy-induced alopecia in rodent models. Cell Stress Chaperones (2008) 1.06
Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain. Int J Cancer (2012) 1.02
Heparanase regulates murine hair growth. Am J Pathol (2005) 0.97
Therapeutic strategy for hair regeneration: hair cycle activation, niche environment modulation, wound-induced follicle neogenesis, and stem cell engineering. Expert Opin Biol Ther (2013) 0.95
A new role for neurotrophin-3: involvement in the regulation of hair follicle regression (catagen). Am J Pathol (1998) 0.94
Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy. Am J Pathol (2007) 0.92
Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia. J Dermatol Sci (2010) 0.92
Mitochondrial function in murine skin epithelium is crucial for hair follicle morphogenesis and epithelial-mesenchymal interactions. J Invest Dermatol (2014) 0.90
Identification of a cyclosporine-specific P450 hydroxylase gene through targeted cytochrome P450 complement (CYPome) disruption in Sebekia benihana. Appl Environ Microbiol (2013) 0.89
Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model. Anticancer Drugs (2014) 0.86
Overexpression of Bcl-2 protects from ultraviolet B-induced apoptosis but promotes hair follicle regression and chemotherapy-induced alopecia. Am J Pathol (2000) 0.85
A novel rat model for chemotherapy-induced alopecia. Clin Exp Dermatol (2012) 0.84
FGF5 and the murine hair cycle. Arch Dermatol Res (1996) 0.80
Animal models of skin disease for drug discovery. Expert Opin Drug Discov (2013) 0.79
Biophysical monitoring of melanogenesis as a tool for pigment and hair research. Arch Dermatol Res (1995) 0.79
Testing chemotherapeutic agents in the feather follicle identifies a selective blockade of cell proliferation and a key role for sonic hedgehog signaling in chemotherapy-induced tissue damage. J Invest Dermatol (2014) 0.79
Role for the epidermal growth factor receptor in chemotherapy-induced alopecia. PLoS One (2013) 0.78
Supportive cryotherapy: a review from head to toe. J Pain Symptom Manage (2013) 0.77
Suppression of eukaryotic initiation factor 4E prevents chemotherapy-induced alopecia. BMC Pharmacol Toxicol (2013) 0.77
Complex changes in the apoptotic and cell differentiation programs during initiation of the hair follicle response to chemotherapy. J Invest Dermatol (2014) 0.77
Macrophages induce AKT/β-catenin-dependent Lgr5(+) stem cell activation and hair follicle regeneration through TNF. Nat Commun (2017) 0.77
A study on the extracts of Cuscuta reflexa Roxb. in treatment of cyclophosphamide induced alopecia. Daru (2014) 0.75
Mycophenolate antagonizes IFN-γ-induced catagen-like changes via β-catenin activation in human dermal papilla cells and hair follicles. Int J Mol Sci (2014) 0.75
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (1980) 17.69
Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell (1990) 12.13
The secret life of the hair follicle. Trends Genet (1992) 4.94
Apoptosis and programmed cell death in immunity. Annu Rev Immunol (1992) 4.47
Growth of the hair. Physiol Rev (1954) 2.77
Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol (1993) 1.88
Telogen effluvium. New concepts and review. Arch Dermatol (1993) 1.79
Growth and differentiation of hair follicles between periods of activity and quiescence. J Exp Zool (1961) 1.75
Telogen skin contains an inhibitor of hair growth. Br J Dermatol (1990) 1.64
Melanocytes as "sensory" and regulatory cells in the epidermis. J Theor Biol (1993) 1.55
Differential expression and activity of melanogenesis-related proteins during induced hair growth in mice. J Invest Dermatol (1991) 1.24
The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration. Lab Invest (1989) 1.22
[EXPERIMENTAL STUDIES ON THE PATHOGENESIS OF "MIXED ALOPECIA" IN ANIMALS]. Arch Klin Exp Dermatol (1964) 1.11
[Pathological reactions at the hair follicle. Clinical and experimental studies of type, cause and significance of deviations from the normal hair root pattern]. Ann Univ Sarav Med (1967) 1.05
Nuclear aberrations in hair follicle cells of patients receiving cyclophosphamide. A possible in vivo assay for human exposure to genotoxic agents. Arch Toxicol (1990) 1.02
[Hair melanogenesis in endoxan alopecia and its modification by corticosteroids]. Arch Klin Exp Dermatol (1966) 1.02
Patterns of cell death: the significance of apoptosis for dermatology. Exp Dermatol (1993) 0.96
Protection from chemotherapy-induced alopecia in a rat model. Science (1990) 0.96
A toxicologic and hematologic evaluation of cyclophosphamide (Cytoxan) in experimental animals. Toxicol Appl Pharmacol (1962) 0.95
Hair shaft elongation, follicle growth, and spontaneous regression in long-term, gelatin sponge-supported histoculture of human scalp skin. Proc Natl Acad Sci U S A (1992) 0.95
Skin histoculture assay for studying the hair cycle. In Vitro Cell Dev Biol (1993) 0.95
Glucocorticoid effect on hair growth initiation: a reconsideration. Skin Pharmacol (1993) 0.94
Interleukin 1 protects from cytosine arabinoside-induced alopecia in the rat model. FASEB J (1991) 0.90
Protection from chemotherapy-induced alopecia by 1,25-dihydroxyvitamin D3. Cancer Res (1992) 0.89
[New perspectives in hair research: in search of the "biological clock" of the hair cycle]. Hautarzt (1992) 0.87
Interleukin 1 protects against 1-beta-D-arabinofuranosylcytosine-induced alopecia in the newborn rat animal model. Cancer Res (1991) 0.78
A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol (2001) 6.12
A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol (1999) 2.92
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol (1993) 2.44
Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol (1995) 1.54
Mast cells. Int J Dermatol (1995) 1.52
Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol (1995) 1.50
Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48
Human mast cells produce IL-8. J Immunol (1993) 1.44
Development and experience lead to increased volume of subcompartments of the honeybee mushroom body. Behav Neural Biol (1994) 1.44
[Recurrent nodular panniculitis in alpha 1-antitrypsin deficiency. Successful dapsone therapy]. Hautarzt (1993) 1.39
Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34
Active hair growth (anagen) is associated with angiogenesis. J Invest Dermatol (2000) 1.29
Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.27
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26
Eosinophil chemotactic factor (ECF). II. Release from human polymorphonuclear leukocytes during phagocytosis. J Immunol (1976) 1.22
Generation and cyclic remodeling of the hair follicle immune system in mice. J Invest Dermatol (1998) 1.22
Hair cycle-dependent plasticity of skin and hair follicle innervation in normal murine skin. J Comp Neurol (1997) 1.20
A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J Invest Dermatol (1994) 1.18
Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol (1994) 1.18
Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol (1997) 1.17
Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol (1981) 1.15
Leukotriene B4 induces in vitro fibroblast chemotaxis. J Invest Dermatol (1984) 1.13
Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol (1994) 1.08
Tumour progression and metastatic behaviour in vivo correlates with integrin expression on melanocytic tumours. J Pathol (1993) 1.08
Octopamine-like immunoreactivity in the brain and subesophageal ganglion of the honeybee. J Comp Neurol (1994) 1.06
Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06
Molecular and functional aspects of anionic channels activated during regulatory volume decrease in mammalian cells. Pflugers Arch (2002) 1.04
Keratin 17 gene expression during the murine hair cycle. J Invest Dermatol (1997) 1.03
Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Cancer Res (1996) 1.02
Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res (1994) 1.02
Transforming growth factor-beta receptor type I and type II expression during murine hair follicle development and cycling. J Invest Dermatol (1997) 1.01
In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products. Prostaglandins (1985) 0.98
Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res (1994) 0.98
Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest (1997) 0.98
Demonstration of the high-affinity IgE receptor on human Langerhans cells in normal and diseased skin. Br J Dermatol (1993) 0.97
Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97
Patterns of cell death: the significance of apoptosis for dermatology. Exp Dermatol (1993) 0.96
Hair growth induction by substance P. Lab Invest (1994) 0.96
Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J Invest Dermatol (1984) 0.95
Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-w-oxidation products in vitro. Prostaglandins (1986) 0.95
Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). J Invest Dermatol (1994) 0.94
Biological and chemical characterization of eosinophil chemotactic factors from human leukocytes. Agents Actions Suppl (1983) 0.93
Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst (1995) 0.92
Chemotactic leukotrienes in psoriasis. Lancet (1982) 0.92
Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate. Br J Dermatol (1981) 0.91
Distribution and changing density of gamma-delta T cells in murine skin during the induced hair cycle. Br J Dermatol (1994) 0.91
P-glycoprotein expression in primary and metastatic malignant melanoma. Br J Dermatol (1995) 0.91
SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma. Br J Dermatol (2004) 0.91
Ultrastructure of inclusions in peripheral blood mononuclear cells in sarcoidosis. Am J Pathol (1975) 0.91
Substance P stimulates murine epidermal keratinocyte proliferation and dermal mast cell degranulation in situ. Arch Dermatol Res (1995) 0.91
In vitro generation of mast cell-like cells from human peripheral mononuclear phagocytes. Int Arch Allergy Appl Immunol (1983) 0.90
Topical treatment of multiple actinic keratoses of the face with arotinoid methyl sulfone (Ro 14-9706) cream versus tretinoin cream: a double-blind, comparative study. J Am Acad Dermatol (1991) 0.90
A simple immunofluorescence technique for simultaneous visualization of mast cells and nerve fibers reveals selectivity and hair cycle--dependent changes in mast cell--nerve fiber contacts in murine skin. Arch Dermatol Res (1997) 0.90
Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes I. Analysis of the in vitro migration of human neutrophils. Chem Phys Lipids (1981) 0.90
Evidence that water acts as a carrier for an epidermal antigen in aquagenic urticaria. J Am Acad Dermatol (1986) 0.90
Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells. Int Arch Allergy Immunol (1996) 0.90
Morphology of the cellular infiltrate in delayed pressure urticaria. J Am Acad Dermatol (1985) 0.89
Development of human connective tissue mast cells from purified blood monocytes. Immunology (1984) 0.89
Mast cells as modulators of hair follicle cycling. Exp Dermatol (1995) 0.89
Foreign-body granuloma and IgE-pseudolymphoma after multiple bee stings. Br J Dermatol (1994) 0.89
Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline. Acta Derm Venereol (1995) 0.89
Detection of human papillomaviruses in paraffin-embedded condylomata acuminata--comparison of immunohistochemistry, in situ hybridization, and polymerase chain reaction. J Invest Dermatol (1991) 0.88
Characterization of gene regulatory elements for selective gene expression in human melanoma cells. Biochem Biophys Res Commun (1995) 0.88
Studies on the role of leukotrienes in murine allergic and irritant contact dermatitis. Br J Dermatol (1988) 0.88
Neural mechanisms of hair growth control. J Investig Dermatol Symp Proc (1997) 0.88
Monoclonal antibodies to leucosialin (CD43) induce homotypic aggregation of the human mast cell line HMC-1: characterization of leucosialin on HMC-1 cells. Immunology (1994) 0.87
Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes. Arch Dermatol Res (1984) 0.87
[New perspectives in hair research: in search of the "biological clock" of the hair cycle]. Hautarzt (1992) 0.87
Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. J Invest Dermatol (1996) 0.87
In vitro differentiation of rat peritoneal macrophages into mast cells: an enzymecytochemical study. Blut (1982) 0.86
Primary leiomyosarcoma of the skin. A histological and immunohistochemical analysis. Acta Derm Venereol (1993) 0.86
Clinical, pharmacological and immunological aspects of delayed pressure urticaria. Br J Dermatol (1984) 0.86
Interleukin-6 expression in the skin of patients with lupus erythematosus. Exp Dermatol (1995) 0.86
Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies. Dermatologica (1988) 0.85
Overexpression of Bcl-2 protects from ultraviolet B-induced apoptosis but promotes hair follicle regression and chemotherapy-induced alopecia. Am J Pathol (2000) 0.85
Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol (1995) 0.85
Production of LTB4-like chemotactic arachidonate metabolites from human keratinocytes. J Invest Dermatol (1985) 0.85
Correlation of proteolytic activities of organ cultured intact mouse skin with defined hair cycle stages. J Dermatol Sci (1994) 0.85
Nerve growth factor modulates keratinocyte proliferation in murine skin organ culture. Br J Dermatol (1994) 0.85
Expression of classical and non-classical MHC class I antigens in murine hair follicles. Br J Dermatol (1994) 0.85
Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations. J Invest Dermatol (1984) 0.84
Comparative studies on eosinophil chemotactic factors during leukocyte migration under agarose. J Invest Dermatol (1982) 0.84
Eosinophils chemotactic factor (ECF). IV. Inhibitory activity in human peripheral leukocytes. Int Arch Allergy Appl Immunol (1978) 0.84
[Annular elastolytic giant cell granuloma with a spontaneous healing tendency]. Hautarzt (1995) 0.83
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity. Cancer (1994) 0.83
Eosinophil chemotactic factor (ECF). III. Generation in human peripheral leukocytes. Int Arch Allergy Appl Immunol (1978) 0.83
Amelanotic malignant melanoma presenting as malignant schwannoma. Br J Dermatol (1993) 0.83
Expression of growth factor receptors on human melanoma cells: comparison of modulating effects of interferons and retinoids. Exp Dermatol (1993) 0.82
Mast cells in melanocytic tumours. Arch Dermatol Res (1995) 0.82
A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica (1983) 0.82